Загрузка...
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD...
Сохранить в:
| Опубликовано в: : | Front Neurol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7304367/ https://ncbi.nlm.nih.gov/pubmed/32595595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00556 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|